Meza Víctor, Arnold Jorge, Díaz Luis Antonio, Ayala Valverde María, Idalsoaga Francisco, Ayares Gustavo, Devuni Deepika, Arab Juan Pablo
Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
Alcohol Alcohol. 2022 May 10;57(3):283-291. doi: 10.1093/alcalc/agac013.
Alcohol consumption represents a major factor of morbidity and mortality, with a wide range of adverse medical implications that practically affect every organ system. It is the fifth major cause of deaths in men and women and causes up to 139 million disability-adjusted life years. Solid evidence places the risk as undoubtedly correlated to the length of time and amount of alcohol consumption. While alcohol-related liver disease represents one of the most studied and well-known consequences of alcohol use, the term itself embodies a wide spectrum of progressive disease stages that are responsible for almost half of the liver-related mortality worldwide. We discuss the staged alcohol-related fatty liver, alcohol-related steatohepatitis and, finally, fibrosis and cirrhosis, which ultimately may end up in a hepatocellular carcinoma. Other comorbidities such as acute and chronic pancreatitis; central nervous system; cardiovascular, respiratory and endocrine system; renal disease; urological pathologies; type 2 diabetes mellitus and even infectious diseases are reviewed in their relation to alcohol consumption. This article reviews the impact of alcohol use on different systems and organs, summarizing available evidence regarding its medical implications. It examines current basic and clinical data regarding mechanisms to highlight factors and processes that may be targetable to improve patient outcomes. Although alcohol use is a part of many cultural and social practices, as healthcare providers we must identify populations at high risk of alcohol abuse, educate patients about the potential alcohol-related harm and provide appropriate treatment.
饮酒是发病和死亡的一个主要因素,具有广泛的不良医学影响,几乎累及每个器官系统。它是男性和女性死亡的第五大主要原因,导致多达1.39亿伤残调整生命年。确凿证据表明,风险无疑与饮酒时间长短和饮酒量相关。虽然酒精性肝病是饮酒最常被研究且最为人所知的后果之一,但该术语本身涵盖了一系列进展性疾病阶段,这些阶段导致了全球近一半的肝脏相关死亡率。我们将讨论分期的酒精性脂肪肝、酒精性脂肪性肝炎,最后是纤维化和肝硬化,它们最终可能发展为肝细胞癌。还将回顾其他合并症,如急性和慢性胰腺炎;中枢神经系统;心血管、呼吸和内分泌系统;肾脏疾病;泌尿系统疾病;2型糖尿病,甚至传染病与饮酒的关系。本文回顾了饮酒对不同系统和器官的影响,总结了有关其医学影响的现有证据。它研究了当前关于机制的基础和临床数据,以突出可能成为改善患者预后靶点的因素和过程。尽管饮酒是许多文化和社会习俗的一部分,但作为医疗服务提供者,我们必须识别出酒精滥用的高危人群,教育患者了解与酒精相关的潜在危害,并提供适当的治疗。